TCGA-OL-A66K	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-OL-A66K
TCGA-OL-A66J	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-OL-A66J
TCGA-OL-A66I	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-OL-A66I
TCGA-OL-A66H	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-OL-A66H
TCGA-LQ-A4E4	25-75% (Moderate) 	Absent	NA	Absent	NA	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-LQ-A4E4
TCGA-LL-A5YP	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-LL-A5YP
TCGA-LL-A5YO	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-LL-A5YO
TCGA-LL-A5YN	25-75% (Moderate) 	Present	Present	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-LL-A5YN
TCGA-LL-A5YM	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-LL-A5YM
TCGA-LL-A5YL	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-LL-A5YL
TCGA-LL-A50Y	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-LL-A50Y
TCGA-LL-A442	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-LL-A442
TCGA-LL-A441	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-LL-A441
TCGA-LL-A440	25-75% (Moderate) 	Absent	Present	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-LL-A440
TCGA-JL-A3YX	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-JL-A3YX
TCGA-JL-A3YW	NA	Present	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-JL-A3YW
TCGA-GM-A4E0	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-GM-A4E0
TCGA-GM-A3XN	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-GM-A3XN
TCGA-GM-A3XL	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-GM-A3XL
TCGA-GM-A3XG	>75% (High)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-GM-A3XG
TCGA-GM-A3NY	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-GM-A3NY
TCGA-GM-A3NW	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-GM-A3NW
TCGA-GM-A2DO	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-GM-A2DO
TCGA-GM-A2DN	25-75% (Moderate) 	Present	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-GM-A2DN
TCGA-GM-A2DM	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-GM-A2DM
TCGA-GM-A2DL	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-GM-A2DL
TCGA-GM-A2DK	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-GM-A2DK
TCGA-GM-A2DI	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-GM-A2DI
TCGA-GM-A2DH	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-GM-A2DH
TCGA-GM-A2DF	<25% (Low)	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-GM-A2DF
TCGA-GM-A2DD	25-75% (Moderate) 	Present	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-GM-A2DD
TCGA-GM-A2DC	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	NA	Invasive Ductal Carcinoma	TCGA-GM-A2DC
TCGA-GM-A2DB	>75% (High)	Present	Absent	1-5% (Minimum)	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-GM-A2DB
TCGA-GM-A2DA	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-GM-A2DA
TCGA-GM-A2D9	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-GM-A2D9
TCGA-GI-A2C9	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-GI-A2C9
TCGA-GI-A2C8	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	NA	Invasive Ductal Carcinoma	TCGA-GI-A2C8
TCGA-EW-A424	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-EW-A424
TCGA-EW-A423	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-EW-A423
TCGA-EW-A3U0	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-EW-A3U0
TCGA-EW-A3E8	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-EW-A3E8
TCGA-EW-A2FW	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-EW-A2FW
TCGA-EW-A2FV	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-EW-A2FV
TCGA-EW-A2FS	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A2FS
TCGA-EW-A2FR	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A2FR
TCGA-EW-A1PH	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-EW-A1PH
TCGA-EW-A1PG	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-EW-A1PG
TCGA-EW-A1PF	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A1PF
TCGA-EW-A1PE	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-EW-A1PE
TCGA-EW-A1PD	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-EW-A1PD
TCGA-EW-A1PC	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-EW-A1PC
TCGA-EW-A1PB	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-EW-A1PB
TCGA-EW-A1PA	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-EW-A1PA
TCGA-EW-A1P8	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-EW-A1P8
TCGA-EW-A1P7	<25% (Low)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-EW-A1P7
TCGA-EW-A1P6	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A1P6
TCGA-EW-A1P5	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A1P5
TCGA-EW-A1P4	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-EW-A1P4
TCGA-EW-A1P3	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A1P3
TCGA-EW-A1P0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-EW-A1P0
TCGA-EW-A1OZ	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-EW-A1OZ
TCGA-EW-A1OY	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-EW-A1OY
TCGA-EW-A1OX	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-EW-A1OX
TCGA-EW-A1OW	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A1OW
TCGA-EW-A1OV	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	NA	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-EW-A1OV
TCGA-EW-A1J6	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-EW-A1J6
TCGA-EW-A1J3	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-EW-A1J3
TCGA-EW-A1J2	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-EW-A1J2
TCGA-EW-A1J1	>75% (High)	Absent	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A1J1
TCGA-EW-A1IY	>75% (High)	Absent	Absent	1-5% (Minimum)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-EW-A1IY
TCGA-EW-A1IX	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	NA	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-EW-A1IX
TCGA-EW-A1IW	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-EW-A1IW
TCGA-E9-A5UP	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	NA	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-E9-A5UP
TCGA-E9-A5UO	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-E9-A5UO
TCGA-E9-A54X	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-E9-A54X
TCGA-E9-A3X8	<25% (Low)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-E9-A3X8
TCGA-E9-A3QA	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-E9-A3QA
TCGA-E9-A3Q9	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-E9-A3Q9
TCGA-E9-A3HO	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Mixed	TCGA-E9-A3HO
TCGA-E9-A2JT	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E9-A2JT
TCGA-E9-A2JS	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Lobular Carcinoma	TCGA-E9-A2JS
TCGA-E9-A295	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-E9-A295
TCGA-E9-A24A	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A24A
TCGA-E9-A249	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A249
TCGA-E9-A248	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A248
TCGA-E9-A247	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Present	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-E9-A247
TCGA-E9-A245	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-E9-A245
TCGA-E9-A244	25-75% (Moderate) 	Present	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A244
TCGA-E9-A243	25-75% (Moderate) 	Present	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A243
TCGA-E9-A22H	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A22H
TCGA-E9-A22G	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A22G
TCGA-E9-A22E	<25% (Low)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Mixed	TCGA-E9-A22E
TCGA-E9-A22D	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A22D
TCGA-E9-A22B	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A22B
TCGA-E9-A22A	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A22A
TCGA-E9-A229	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A229
TCGA-E9-A228	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-E9-A228
TCGA-E9-A227	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A227
TCGA-E9-A226	25-75% (Moderate) 	Present	Absent	1-5% (Minimum)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A226
TCGA-E9-A1RI	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1RI
TCGA-E9-A1RH	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1RH
TCGA-E9-A1RF	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Mixed	TCGA-E9-A1RF
TCGA-E9-A1RE	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E9-A1RE
TCGA-E9-A1RD	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1RD
TCGA-E9-A1RC	<25% (Low)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1RC
TCGA-E9-A1RB	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Other	TCGA-E9-A1RB
TCGA-E9-A1R7	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1R7
TCGA-E9-A1R6	<25% (Low)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1R6
TCGA-E9-A1R5	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1R5
TCGA-E9-A1R4	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Absent	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-E9-A1R4
TCGA-E9-A1R3	25-75% (Moderate) 	Present	Absent	Absent	Present	>75% (Well Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1R3
TCGA-E9-A1R2	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1R2
TCGA-E9-A1R0	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1R0
TCGA-E9-A1QZ	<25% (Low)	Absent	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1QZ
TCGA-E9-A1NI	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1NI
TCGA-E9-A1NH	<25% (Low)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E9-A1NH
TCGA-E9-A1NG	<25% (Low)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E9-A1NG
TCGA-E9-A1NF	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1NF
TCGA-E9-A1NE	<25% (Low)	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E9-A1NE
TCGA-E9-A1ND	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1ND
TCGA-E9-A1NA	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1NA
TCGA-E9-A1N9	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1N9
TCGA-E9-A1N8	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1N8
TCGA-E9-A1N6	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E9-A1N6
TCGA-E9-A1N5	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1N5
TCGA-E9-A1N4	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E9-A1N4
TCGA-E9-A1N3	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E9-A1N3
TCGA-E2-A574	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A574
TCGA-E2-A573	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A573
TCGA-E2-A570	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A570
TCGA-E2-A56Z	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A56Z
TCGA-E2-A3DX	25-75% (Moderate) 	Present	Present	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A3DX
TCGA-E2-A2P6	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A2P6
TCGA-E2-A2P5	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-E2-A2P5
TCGA-E2-A1LS	>75% (High)	Absent	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Present	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-E2-A1LS
TCGA-E2-A1LL	>75% (High)	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-E2-A1LL
TCGA-E2-A1LK	>75% (High)	Present	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A1LK
TCGA-E2-A1LI	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A1LI
TCGA-E2-A1LH	25-75% (Moderate) 	Present	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A1LH
TCGA-E2-A1LG	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-E2-A1LG
TCGA-E2-A1LE	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A1LE
TCGA-E2-A1LB	>75% (High)	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A1LB
TCGA-E2-A1LA	>75% (High)	Present	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A1LA
TCGA-E2-A1L9	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A1L9
TCGA-E2-A1L8	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A1L8
TCGA-E2-A1L7	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A1L7
TCGA-E2-A1L6	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-E2-A1L6
TCGA-E2-A1IU	<25% (Low)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A1IU
TCGA-E2-A1IO	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A1IO
TCGA-E2-A1IN	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A1IN
TCGA-E2-A1IL	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A1IL
TCGA-E2-A1IK	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-E2-A1IK
TCGA-E2-A1IJ	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A1IJ
TCGA-E2-A1II	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A1II
TCGA-E2-A1IH	<25% (Low)	Present	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A1IH
TCGA-E2-A1IG	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A1IG
TCGA-E2-A1IF	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	NA	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A1IF
TCGA-E2-A1IE	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A1IE
TCGA-E2-A1BD	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A1BD
TCGA-E2-A1BC	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-E2-A1BC
TCGA-E2-A1B6	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A1B6
TCGA-E2-A1B5	25-75% (Moderate) 	Present	Present	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A1B5
TCGA-E2-A1B4	<25% (Low)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A1B4
TCGA-E2-A1B1	<25% (Low)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-E2-A1B1
TCGA-E2-A1B0	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A1B0
TCGA-E2-A1AZ	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A1AZ
TCGA-E2-A15T	<25% (Low)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-E2-A15T
TCGA-E2-A15S	NA	Absent	Absent	NA	Present	NA	Absent	NA	NA	NA	NA	Other	TCGA-E2-A15S
TCGA-E2-A15R	25-75% (Moderate) 	Absent	Present	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-E2-A15R
TCGA-E2-A15P	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Mixed	TCGA-E2-A15P
TCGA-E2-A15O	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A15O
TCGA-E2-A15M	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-E2-A15M
TCGA-E2-A15L	>75% (High)	Absent	Present	1-5% (Minimum)	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A15L
TCGA-E2-A15K	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A15K
TCGA-E2-A15I	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-E2-A15I
TCGA-E2-A15H	<25% (Low)	Absent	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A15H
TCGA-E2-A15G	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-E2-A15G
TCGA-E2-A15F	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A15F
TCGA-E2-A15E	>75% (High)	Present	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A15E
TCGA-E2-A15D	25-75% (Moderate) 	Present	Absent	Absent	Present	>75% (Well Differentiated	Absent	Present	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A15D
TCGA-E2-A15C	<25% (Low)	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A15C
TCGA-E2-A15A	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-E2-A15A
TCGA-E2-A159	25-75% (Moderate) 	Present	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A159
TCGA-E2-A158	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A158
TCGA-E2-A156	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A156
TCGA-E2-A155	<25% (Low)	Present	Absent	1-5% (Minimum)	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Mixed	TCGA-E2-A155
TCGA-E2-A154	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A154
TCGA-E2-A153	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-E2-A153
TCGA-E2-A152	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A152
TCGA-E2-A150	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-E2-A150
TCGA-E2-A14Z	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Mixed	TCGA-E2-A14Z
TCGA-E2-A14Y	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A14Y
TCGA-E2-A14X	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A14X
TCGA-E2-A14W	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A14W
TCGA-E2-A14V	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A14V
TCGA-E2-A14U	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A14U
TCGA-E2-A14T	25-75% (Moderate) 	Absent	Absent	1-5% (Minimum)	Absent	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Other	TCGA-E2-A14T
TCGA-E2-A14S	>75% (High)	Absent	Absent	6-50% (Moderate)	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A14S
TCGA-E2-A14R	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A14R
TCGA-E2-A14Q	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-E2-A14Q
TCGA-E2-A14P	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A14P
TCGA-E2-A14O	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A14O
TCGA-E2-A14N	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A14N
TCGA-E2-A10F	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A10F
TCGA-E2-A10E	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A10E
TCGA-E2-A10C	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A10C
TCGA-E2-A10B	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A10B
TCGA-E2-A10A	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Present	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A10A
TCGA-E2-A109	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-E2-A109
TCGA-E2-A108	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-E2-A108
TCGA-E2-A107	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-E2-A107
TCGA-E2-A106	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-E2-A106
TCGA-E2-A105	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-E2-A105
TCGA-D8-A4Z1	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-D8-A4Z1
TCGA-D8-A3Z6	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-D8-A3Z6
TCGA-D8-A3Z5	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-D8-A3Z5
TCGA-D8-A27W	<25% (Low)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-D8-A27W
TCGA-D8-A27V	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Invasive Lobular Carcinoma	TCGA-D8-A27V
TCGA-D8-A27T	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-D8-A27T
TCGA-D8-A27R	NA	Absent	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A27R
TCGA-D8-A27P	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A27P
TCGA-D8-A27N	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A27N
TCGA-D8-A27M	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A27M
TCGA-D8-A27L	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A27L
TCGA-D8-A27K	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-D8-A27K
TCGA-D8-A27I	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Invasive Lobular Carcinoma	TCGA-D8-A27I
TCGA-D8-A27H	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A27H
TCGA-D8-A27G	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Invasive Lobular Carcinoma	TCGA-D8-A27G
TCGA-D8-A27F	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A27F
TCGA-D8-A27E	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-D8-A27E
TCGA-D8-A1Y3	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1Y3
TCGA-D8-A1Y2	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1Y2
TCGA-D8-A1Y1	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A1Y1
TCGA-D8-A1Y0	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-D8-A1Y0
TCGA-D8-A1XZ	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1XZ
TCGA-D8-A1XY	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1XY
TCGA-D8-A1XW	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A1XW
TCGA-D8-A1XV	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-D8-A1XV
TCGA-D8-A1XU	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1XU
TCGA-D8-A1XT	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1XT
TCGA-D8-A1XS	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	NA	>10 per 10 HPF (High)	Other	TCGA-D8-A1XS
TCGA-D8-A1XR	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A1XR
TCGA-D8-A1XQ	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1XQ
TCGA-D8-A1XO	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Invasive Lobular Carcinoma	TCGA-D8-A1XO
TCGA-D8-A1XM	25-75% (Moderate) 	Present	Present	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-D8-A1XM
TCGA-D8-A1XL	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1XL
TCGA-D8-A1XK	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1XK
TCGA-D8-A1XJ	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Other	TCGA-D8-A1XJ
TCGA-D8-A1XG	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1XG
TCGA-D8-A1XF	25-75% (Moderate) 	Present	Present	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A1XF
TCGA-D8-A1XD	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A1XD
TCGA-D8-A1XC	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-D8-A1XC
TCGA-D8-A1XB	<25% (Low)	Present	Absent	Absent	Present	>75% (Well Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A1XB
TCGA-D8-A1XA	<25% (Low)	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-D8-A1XA
TCGA-D8-A1X9	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	>75% (Well Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A1X9
TCGA-D8-A1X8	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-D8-A1X8
TCGA-D8-A1X7	<25% (Low)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-D8-A1X7
TCGA-D8-A1X6	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-D8-A1X6
TCGA-D8-A1X5	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-D8-A1X5
TCGA-D8-A1JU	<25% (Low)	Absent	Present	Absent	Present	>75% (Well Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-D8-A1JU
TCGA-D8-A1JT	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-D8-A1JT
TCGA-D8-A1JS	>75% (High)	Absent	Present	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-D8-A1JS
TCGA-D8-A1JP	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1JP
TCGA-D8-A1JN	<25% (Low)	Present	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-D8-A1JN
TCGA-D8-A1JM	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-D8-A1JM
TCGA-D8-A1JL	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1JL
TCGA-D8-A1JK	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1JK
TCGA-D8-A1JJ	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-D8-A1JJ
TCGA-D8-A1JI	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1JI
TCGA-D8-A1JH	25-75% (Moderate) 	Present	Absent	1-5% (Minimum)	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A1JH
TCGA-D8-A1JG	>75% (High)	Present	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1JG
TCGA-D8-A1JF	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1JF
TCGA-D8-A1JE	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	10-75% (Moderately Differentiated	Present	Present	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1JE
TCGA-D8-A1JD	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1JD
TCGA-D8-A1JC	<25% (Low)	Present	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A1JC
TCGA-D8-A1JB	<25% (Low)	Present	Present	6-50% (Moderate)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-D8-A1JB
TCGA-D8-A1JA	>75% (High)	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1JA
TCGA-D8-A1J9	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1J9
TCGA-D8-A1J8	>75% (High)	Present	Absent	1-5% (Minimum)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A1J8
TCGA-D8-A147	>75% (High)	Absent	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A147
TCGA-D8-A146	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A146
TCGA-D8-A145	>75% (High)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A145
TCGA-D8-A143	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-D8-A143
TCGA-D8-A142	25-75% (Moderate) 	Present	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A142
TCGA-D8-A141	>75% (High)	Present	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-D8-A141
TCGA-D8-A140	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A140
TCGA-D8-A13Z	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-D8-A13Z
TCGA-D8-A13Y	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-D8-A13Y
TCGA-C8-A3M8	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-C8-A3M8
TCGA-C8-A3M7	<25% (Low)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-C8-A3M7
TCGA-C8-A27B	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A27B
TCGA-C8-A27A	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A27A
TCGA-C8-A278	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A278
TCGA-C8-A275	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A275
TCGA-C8-A274	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-C8-A274
TCGA-C8-A273	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Other	TCGA-C8-A273
TCGA-C8-A26Z	25-75% (Moderate) 	Absent	Absent	NA	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-C8-A26Z
TCGA-C8-A26Y	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A26Y
TCGA-C8-A26X	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A26X
TCGA-C8-A26W	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A26W
TCGA-C8-A26V	>75% (High)	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-C8-A26V
TCGA-C8-A1HO	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A1HO
TCGA-C8-A1HN	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A1HN
TCGA-C8-A1HM	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A1HM
TCGA-C8-A1HL	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-C8-A1HL
TCGA-C8-A1HK	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A1HK
TCGA-C8-A1HJ	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A1HJ
TCGA-C8-A1HI	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A1HI
TCGA-C8-A1HG	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A1HG
TCGA-C8-A1HF	>75% (High)	Present	Absent	1-5% (Minimum)	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A1HF
TCGA-C8-A1HE	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A1HE
TCGA-C8-A138	<25% (Low)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A138
TCGA-C8-A137	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-C8-A137
TCGA-C8-A135	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A135
TCGA-C8-A134	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A134
TCGA-C8-A133	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-C8-A133
TCGA-C8-A132	>75% (High)	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A132
TCGA-C8-A131	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A131
TCGA-C8-A130	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-C8-A130
TCGA-C8-A12Z	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-C8-A12Z
TCGA-C8-A12Y	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A12Y
TCGA-C8-A12X	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-C8-A12X
TCGA-C8-A12W	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-C8-A12W
TCGA-C8-A12V	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A12V
TCGA-C8-A12U	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A12U
TCGA-C8-A12T	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A12T
TCGA-C8-A12Q	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A12Q
TCGA-C8-A12P	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A12P
TCGA-C8-A12O	25-75% (Moderate) 	Present	Absent	1-5% (Minimum)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A12O
TCGA-C8-A12N	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-C8-A12N
TCGA-C8-A12M	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-C8-A12M
TCGA-C8-A12L	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A12L
TCGA-C8-A12K	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-C8-A12K
TCGA-BH-A42V	<25% (Low)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A42V
TCGA-BH-A42U	<25% (Low)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A42U
TCGA-BH-A42T	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Lobular Carcinoma	TCGA-BH-A42T
TCGA-BH-A28Q	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Mixed	TCGA-BH-A28Q
TCGA-BH-A28O	<25% (Low)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A28O
TCGA-BH-A209	>75% (High)	Present	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Other	TCGA-BH-A209
TCGA-BH-A208	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A208
TCGA-BH-A204	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A204
TCGA-BH-A203	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A203
TCGA-BH-A202	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A202
TCGA-BH-A201	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A201
TCGA-BH-A1FU	<25% (Low)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-BH-A1FU
TCGA-BH-A1FR	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-BH-A1FR
TCGA-BH-A1FN	25-75% (Moderate) 	Absent	Present	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A1FN
TCGA-BH-A1FM	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A1FM
TCGA-BH-A1FL	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A1FL
TCGA-BH-A1FJ	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Other	TCGA-BH-A1FJ
TCGA-BH-A1FH	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A1FH
TCGA-BH-A1FG	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A1FG
TCGA-BH-A1FE	<25% (Low)	Absent	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A1FE
TCGA-BH-A1FC	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-BH-A1FC
TCGA-BH-A1FB	<25% (Low)	Absent	Absent	1-5% (Minimum)	Present	>75% (Well Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A1FB
TCGA-BH-A1F8	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A1F8
TCGA-BH-A1F6	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A1F6
TCGA-BH-A1F5	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A1F5
TCGA-BH-A1F2	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A1F2
TCGA-BH-A1F0	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A1F0
TCGA-BH-A1EY	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A1EY
TCGA-BH-A1EX	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A1EX
TCGA-BH-A1EW	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A1EW
TCGA-BH-A1EV	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A1EV
TCGA-BH-A1EU	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A1EU
TCGA-BH-A1ET	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A1ET
TCGA-BH-A1ES	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A1ES
TCGA-BH-A1EO	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A1EO
TCGA-BH-A1EN	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A1EN
TCGA-BH-A18V	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A18V
TCGA-BH-A18U	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A18U
TCGA-BH-A18T	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A18T
TCGA-BH-A18S	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A18S
TCGA-BH-A18R	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A18R
TCGA-BH-A18Q	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A18Q
TCGA-BH-A18P	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A18P
TCGA-BH-A18N	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A18N
TCGA-BH-A18M	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Other	TCGA-BH-A18M
TCGA-BH-A18L	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-BH-A18L
TCGA-BH-A18J	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A18J
TCGA-BH-A18I	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A18I
TCGA-BH-A18H	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A18H
TCGA-BH-A18G	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A18G
TCGA-BH-A18F	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A18F
TCGA-BH-A0WA	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-BH-A0WA
TCGA-BH-A0W7	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0W7
TCGA-BH-A0W5	25-75% (Moderate) 	Present	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0W5
TCGA-BH-A0W4	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Present	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A0W4
TCGA-BH-A0W3	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0W3
TCGA-BH-A0RX	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-BH-A0RX
TCGA-BH-A0HY	>75% (High)	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0HY
TCGA-BH-A0HX	>75% (High)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0HX
TCGA-BH-A0HW	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Present	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A0HW
TCGA-BH-A0HU	>75% (High)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0HU
TCGA-BH-A0HQ	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0HQ
TCGA-BH-A0HP	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A0HP
TCGA-BH-A0HO	>75% (High)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0HO
TCGA-BH-A0HN	>75% (High)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0HN
TCGA-BH-A0HL	>75% (High)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A0HL
TCGA-BH-A0HK	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A0HK
TCGA-BH-A0HI	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0HI
TCGA-BH-A0HF	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0HF
TCGA-BH-A0HB	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0HB
TCGA-BH-A0HA	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0HA
TCGA-BH-A0H9	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0H9
TCGA-BH-A0H7	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0H7
TCGA-BH-A0H6	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A0H6
TCGA-BH-A0H5	25-75% (Moderate) 	Present	NA	Absent	NA	<10% (poorly Differentiated	NA	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0H5
TCGA-BH-A0H3	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	NA	NA	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0H3
TCGA-BH-A0H0	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0H0
TCGA-BH-A0GZ	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0GZ
TCGA-BH-A0GY	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0GY
TCGA-BH-A0EI	<25% (Low)	Present	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0EI
TCGA-BH-A0EE	>75% (High)	Present	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-BH-A0EE
TCGA-BH-A0EB	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0EB
TCGA-BH-A0EA	<25% (Low)	Absent	Present	Absent	Present	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0EA
TCGA-BH-A0E9	<25% (Low)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A0E9
TCGA-BH-A0E7	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A0E7
TCGA-BH-A0E6	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0E6
TCGA-BH-A0E2	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0E2
TCGA-BH-A0E1	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0E1
TCGA-BH-A0E0	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0E0
TCGA-BH-A0DZ	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0DZ
TCGA-BH-A0DX	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0DX
TCGA-BH-A0DV	<25% (Low)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0DV
TCGA-BH-A0DT	25-75% (Moderate) 	Absent	Present	Absent	Present	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0DT
TCGA-BH-A0DS	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0DS
TCGA-BH-A0DQ	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0DQ
TCGA-BH-A0DP	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-BH-A0DP
TCGA-BH-A0DO	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0DO
TCGA-BH-A0DL	>75% (High)	Present	Absent	1-5% (Minimum)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-BH-A0DL
TCGA-BH-A0DK	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0DK
TCGA-BH-A0DI	25-75% (Moderate) 	NA	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0DI
TCGA-BH-A0DH	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-BH-A0DH
TCGA-BH-A0DG	>75% (High)	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0DG
TCGA-BH-A0DE	<25% (Low)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0DE
TCGA-BH-A0DD	>75% (High)	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0DD
TCGA-BH-A0C7	<25% (Low)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0C7
TCGA-BH-A0C3	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A0C3
TCGA-BH-A0C1	25-75% (Moderate) 	Absent	Present	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A0C1
TCGA-BH-A0C0	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0C0
TCGA-BH-A0BZ	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-BH-A0BZ
TCGA-BH-A0BW	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0BW
TCGA-BH-A0BV	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0BV
TCGA-BH-A0BS	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0BS
TCGA-BH-A0BR	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0BR
TCGA-BH-A0BQ	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0BQ
TCGA-BH-A0BP	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0BP
TCGA-BH-A0BO	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0BO
TCGA-BH-A0BM	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0BM
TCGA-BH-A0BL	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0BL
TCGA-BH-A0BJ	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0BJ
TCGA-BH-A0BG	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0BG
TCGA-BH-A0BF	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0BF
TCGA-BH-A0BD	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0BD
TCGA-BH-A0BC	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0BC
TCGA-BH-A0BA	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A0BA
TCGA-BH-A0B9	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0B9
TCGA-BH-A0B8	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0B8
TCGA-BH-A0B7	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-BH-A0B7
TCGA-BH-A0B6	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0B6
TCGA-BH-A0B5	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-BH-A0B5
TCGA-BH-A0B4	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0B4
TCGA-BH-A0B3	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0B3
TCGA-BH-A0B1	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0B1
TCGA-BH-A0B0	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0B0
TCGA-BH-A0AZ	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0AZ
TCGA-BH-A0AY	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0AY
TCGA-BH-A0AW	<25% (Low)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-BH-A0AW
TCGA-BH-A0AV	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-BH-A0AV
TCGA-BH-A0AU	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-BH-A0AU
TCGA-B6-A2IU	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Invasive Lobular Carcinoma	TCGA-B6-A2IU
TCGA-B6-A1KN	25-75% (Moderate) 	Absent	Present	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A1KN
TCGA-B6-A1KI	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A1KI
TCGA-B6-A1KF	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A1KF
TCGA-B6-A1KC	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-B6-A1KC
TCGA-B6-A0X7	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-B6-A0X7
TCGA-B6-A0X5	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0X5
TCGA-B6-A0X4	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0X4
TCGA-B6-A0X1	>75% (High)	Present	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0X1
TCGA-B6-A0X0	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Present	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-B6-A0X0
TCGA-B6-A0WZ	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0WZ
TCGA-B6-A0WY	<25% (Low)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-B6-A0WY
TCGA-B6-A0WX	<25% (Low)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-B6-A0WX
TCGA-B6-A0WW	<25% (Low)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0WW
TCGA-B6-A0WV	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0WV
TCGA-B6-A0WT	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-B6-A0WT
TCGA-B6-A0WS	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0WS
TCGA-B6-A0RV	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-B6-A0RV
TCGA-B6-A0RU	<25% (Low)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Other	TCGA-B6-A0RU
TCGA-B6-A0RT	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Mixed	TCGA-B6-A0RT
TCGA-B6-A0RS	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-B6-A0RS
TCGA-B6-A0RQ	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-B6-A0RQ
TCGA-B6-A0RP	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Mixed	TCGA-B6-A0RP
TCGA-B6-A0RO	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0RO
TCGA-B6-A0RN	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-B6-A0RN
TCGA-B6-A0RI	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0RI
TCGA-B6-A0RH	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-B6-A0RH
TCGA-B6-A0RG	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-B6-A0RG
TCGA-B6-A0RE	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-B6-A0RE
TCGA-B6-A0IQ	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-B6-A0IQ
TCGA-B6-A0IP	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-B6-A0IP
TCGA-B6-A0IO	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-B6-A0IO
TCGA-B6-A0IN	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-B6-A0IN
TCGA-B6-A0IM	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-B6-A0IM
TCGA-B6-A0IK	>75% (High)	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-B6-A0IK
TCGA-B6-A0IJ	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-B6-A0IJ
TCGA-B6-A0IH	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-B6-A0IH
TCGA-B6-A0IG	>75% (High)	NA	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0IG
TCGA-B6-A0IE	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-B6-A0IE
TCGA-B6-A0IC	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	>75% (Well Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-B6-A0IC
TCGA-B6-A0IB	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	NA	Invasive Ductal Carcinoma	TCGA-B6-A0IB
TCGA-B6-A0IA	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-B6-A0IA
TCGA-B6-A0I9	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-B6-A0I9
TCGA-B6-A0I8	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0I8
TCGA-B6-A0I6	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Mixed	TCGA-B6-A0I6
TCGA-B6-A0I5	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-B6-A0I5
TCGA-B6-A0I2	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-B6-A0I2
TCGA-AR-A24S	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A24S
TCGA-AR-A24R	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A24R
TCGA-AR-A24Q	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A24Q
TCGA-AR-A24P	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A24P
TCGA-AR-A24O	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-AR-A24O
TCGA-AR-A24N	>75% (High)	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A24N
TCGA-AR-A24M	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A24M
TCGA-AR-A24L	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A24L
TCGA-AR-A24K	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A24K
TCGA-AR-A1AY	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A1AY
TCGA-AR-A1AX	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A1AX
TCGA-AR-A1AW	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-AR-A1AW
TCGA-AR-A1AV	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A1AV
TCGA-AR-A1AU	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A1AU
TCGA-AR-A1AS	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AR-A1AS
TCGA-AR-A1AR	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-AR-A1AR
TCGA-AR-A1AQ	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A1AQ
TCGA-AR-A1AP	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-AR-A1AP
TCGA-AR-A1AO	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-AR-A1AO
TCGA-AR-A1AN	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AR-A1AN
TCGA-AR-A1AM	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AR-A1AM
TCGA-AR-A1AJ	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A1AJ
TCGA-AR-A1AI	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-AR-A1AI
TCGA-AR-A1AH	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AR-A1AH
TCGA-AR-A0U3	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A0U3
TCGA-AR-A0U2	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A0U2
TCGA-AR-A0U0	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A0U0
TCGA-AR-A0TZ	>75% (High)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	NA	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A0TZ
TCGA-AR-A0TY	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AR-A0TY
TCGA-AR-A0TX	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-AR-A0TX
TCGA-AR-A0TW	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-AR-A0TW
TCGA-AR-A0TV	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AR-A0TV
TCGA-AR-A0TU	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A0TU
TCGA-AR-A0TT	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A0TT
TCGA-AR-A0TS	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A0TS
TCGA-AR-A0TR	>75% (High)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AR-A0TR
TCGA-AR-A0TQ	25-75% (Moderate) 	Present	Absent	6-50% (Moderate)	Absent	10-75% (Moderately Differentiated	Present	Present	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A0TQ
TCGA-AR-A0TP	>75% (High)	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AR-A0TP
TCGA-AQ-A54O	>75% (High)	Present	Absent	6-50% (Moderate)	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AQ-A54O
TCGA-AQ-A54N	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AQ-A54N
TCGA-AQ-A1H3	25-75% (Moderate) 	Present	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AQ-A1H3
TCGA-AQ-A1H2	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AQ-A1H2
TCGA-AQ-A0Y5	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-AQ-A0Y5
TCGA-AQ-A04L	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AQ-A04L
TCGA-AQ-A04J	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AQ-A04J
TCGA-AQ-A04H	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-AQ-A04H
TCGA-AO-A1KT	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AO-A1KT
TCGA-AO-A1KS	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Mixed	TCGA-AO-A1KS
TCGA-AO-A1KR	>75% (High)	NA	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AO-A1KR
TCGA-AO-A1KQ	>75% (High)	Present	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AO-A1KQ
TCGA-AO-A1KP	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AO-A1KP
TCGA-AO-A1KO	>75% (High)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AO-A1KO
TCGA-AO-A128	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-AO-A128
TCGA-AN-A0XU	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0XU
TCGA-AN-A0G0	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0G0
TCGA-AN-A0FZ	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AN-A0FZ
TCGA-AN-A0FY	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0FY
TCGA-AN-A0FX	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0FX
TCGA-AN-A0FW	<25% (Low)	Absent	Present	Absent	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-AN-A0FW
TCGA-AN-A0FV	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AN-A0FV
TCGA-AN-A0FT	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-AN-A0FT
TCGA-AN-A0FS	<25% (Low)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-AN-A0FS
TCGA-AN-A0FN	<25% (Low)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-AN-A0FN
TCGA-AN-A0FL	>75% (High)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-AN-A0FL
TCGA-AN-A0FK	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AN-A0FK
TCGA-AN-A0FJ	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0FJ
TCGA-AN-A0FF	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AN-A0FF
TCGA-AN-A0AT	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0AT
TCGA-AN-A0AS	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0AS
TCGA-AN-A0AM	>75% (High)	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0AM
TCGA-AN-A0AL	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0AL
TCGA-AN-A0AK	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AN-A0AK
TCGA-AN-A0AJ	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AN-A0AJ
TCGA-AN-A04D	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	NA	Invasive Ductal Carcinoma	TCGA-AN-A04D
TCGA-AC-A62Y	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A62Y
TCGA-AC-A5XS	>75% (High)	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A5XS
TCGA-AC-A3YI	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A3YI
TCGA-AC-A3W7	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-AC-A3W7
TCGA-AC-A3W6	25-75% (Moderate) 	Absent	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A3W6
TCGA-AC-A3W5	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-AC-A3W5
TCGA-AC-A3TN	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A3TN
TCGA-AC-A3TM	>75% (High)	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AC-A3TM
TCGA-AC-A3QQ	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AC-A3QQ
TCGA-AC-A3QP	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A3QP
TCGA-AC-A3OD	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A3OD
TCGA-AC-A3HN	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A3HN
TCGA-AC-A3EH	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A3EH
TCGA-AC-A3BB	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A3BB
TCGA-AC-A2QJ	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-AC-A2QJ
TCGA-AC-A2QI	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A2QI
TCGA-AC-A2QH	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-AC-A2QH
TCGA-AC-A2FO	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A2FO
TCGA-AC-A2FM	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-AC-A2FM
TCGA-AC-A2FK	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A2FK
TCGA-AC-A2FG	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A2FG
TCGA-AC-A2FF	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Invasive Lobular Carcinoma	TCGA-AC-A2FF
TCGA-AC-A2FE	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A2FE
TCGA-AC-A2FB	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-AC-A2FB
TCGA-AC-A2BM	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-AC-A2BM
TCGA-AC-A2BK	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-AC-A2BK
TCGA-AC-A2B8	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A2B8
TCGA-AC-A23H	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AC-A23H
TCGA-AC-A23G	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-AC-A23G
TCGA-AC-A23E	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-AC-A23E
TCGA-AC-A23C	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-AC-A23C
TCGA-A8-A0AD	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A8-A0AD
TCGA-A8-A0A9	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A0A9
TCGA-A8-A0A7	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A8-A0A7
TCGA-A8-A0A4	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A8-A0A4
TCGA-A8-A0A2	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A8-A0A2
TCGA-A8-A0A1	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A8-A0A1
TCGA-A8-A09Z	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A8-A09Z
TCGA-A8-A09X	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-A8-A09X
TCGA-A8-A09W	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A8-A09W
TCGA-A8-A09V	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A8-A09V
TCGA-A8-A09T	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A8-A09T
TCGA-A8-A09R	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A09R
TCGA-A8-A09Q	>75% (High)	Present	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A09Q
TCGA-A8-A09N	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A09N
TCGA-A8-A09M	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A09M
TCGA-A8-A09K	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Mixed	TCGA-A8-A09K
TCGA-A8-A09I	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A09I
TCGA-A8-A09G	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A09G
TCGA-A8-A09D	>75% (High)	Absent	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A09D
TCGA-A8-A09C	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-A8-A09C
TCGA-A8-A09B	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A09B
TCGA-A8-A09A	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A09A
TCGA-A8-A099	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A099
TCGA-A8-A097	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A097
TCGA-A8-A096	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A096
TCGA-A8-A095	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A095
TCGA-A8-A094	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A094
TCGA-A8-A093	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A093
TCGA-A8-A092	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A092
TCGA-A8-A091	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A091
TCGA-A8-A090	>75% (High)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A090
TCGA-A8-A08Z	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A08Z
TCGA-A8-A08X	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A08X
TCGA-A8-A08T	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A08T
TCGA-A8-A08S	>75% (High)	Absent	Absent	6-50% (Moderate)	Present	>75% (Well Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A08S
TCGA-A8-A08R	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A08R
TCGA-A8-A08P	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A08P
TCGA-A8-A08O	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A08O
TCGA-A8-A08L	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A08L
TCGA-A8-A08J	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A08J
TCGA-A8-A08I	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A08I
TCGA-A8-A08H	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A08H
TCGA-A8-A08G	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A08G
TCGA-A8-A08F	>75% (High)	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A08F
TCGA-A8-A08C	>75% (High)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A08C
TCGA-A8-A08B	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A08B
TCGA-A8-A086	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A086
TCGA-A8-A085	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A085
TCGA-A8-A084	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A084
TCGA-A8-A083	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Present	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A8-A083
TCGA-A8-A082	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-A8-A082
TCGA-A8-A081	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	NA	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A081
TCGA-A8-A07W	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A07W
TCGA-A8-A07U	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A07U
TCGA-A8-A07S	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A07S
TCGA-A8-A07R	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A07R
TCGA-A8-A07P	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A07P
TCGA-A8-A07O	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A07O
TCGA-A8-A07L	25-75% (Moderate) 	Absent	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-A8-A07L
TCGA-A8-A07J	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A07J
TCGA-A8-A07I	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A07I
TCGA-A8-A07G	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-A8-A07G
TCGA-A8-A07F	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-A8-A07F
TCGA-A8-A07E	<25% (Low)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-A8-A07E
TCGA-A8-A07C	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A07C
TCGA-A8-A07B	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-A8-A07B
TCGA-A8-A079	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A079
TCGA-A8-A076	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	NA	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A076
TCGA-A8-A075	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A075
TCGA-A8-A06Z	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A06Z
TCGA-A8-A06Y	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	NA	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A06Y
TCGA-A8-A06X	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Mixed	TCGA-A8-A06X
TCGA-A8-A06U	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	NA	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A06U
TCGA-A8-A06T	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	NA	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A06T
TCGA-A8-A06R	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	NA	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A8-A06R
TCGA-A8-A06Q	>75% (High)	NA	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A06Q
TCGA-A8-A06P	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A8-A06P
TCGA-A8-A06O	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A8-A06O
TCGA-A8-A06N	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Present	Present	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A8-A06N
TCGA-A7-A5ZX	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A5ZX
TCGA-A7-A5ZW	<25% (Low)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A7-A5ZW
TCGA-A7-A5ZV	>75% (High)	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-A7-A5ZV
TCGA-A7-A4SF	>75% (High)	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A7-A4SF
TCGA-A7-A4SE	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A7-A4SE
TCGA-A7-A4SD	>75% (High)	Present	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A7-A4SD
TCGA-A7-A4SC	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A4SC
TCGA-A7-A4SB	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A4SB
TCGA-A7-A4SA	25-75% (Moderate) 	Absent	Present	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-A7-A4SA
TCGA-A7-A426	<25% (Low)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A426
TCGA-A7-A425	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	Other	TCGA-A7-A425
TCGA-A7-A3RF	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A7-A3RF
TCGA-A7-A3J1	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A3J1
TCGA-A7-A3J0	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A7-A3J0
TCGA-A7-A3IZ	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A3IZ
TCGA-A7-A3IY	<25% (Low)	Absent	Absent	NA	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A7-A3IY
TCGA-A7-A2KD	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A7-A2KD
TCGA-A7-A26J	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	NA	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A7-A26J
TCGA-A7-A26I	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	NA	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A7-A26I
TCGA-A7-A26H	<25% (Low)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-A7-A26H
TCGA-A7-A26G	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A7-A26G
TCGA-A7-A26F	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-A7-A26F
TCGA-A7-A26E	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A26E
TCGA-A7-A13H	<25% (Low)	Absent	Present	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A13H
TCGA-A7-A13G	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A7-A13G
TCGA-A7-A13F	>75% (High)	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Mixed	TCGA-A7-A13F
TCGA-A7-A13E	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A7-A13E
TCGA-A7-A13D	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A7-A13D
TCGA-A7-A0DB	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A7-A0DB
TCGA-A7-A0DA	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A7-A0DA
TCGA-A7-A0D9	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A7-A0D9
TCGA-A7-A0CJ	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A7-A0CJ
TCGA-A7-A0CH	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A7-A0CH
TCGA-A7-A0CG	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A7-A0CG
TCGA-A7-A0CE	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A7-A0CE
TCGA-A7-A0CD	25-75% (Moderate) 	Absent	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A7-A0CD
TCGA-A2-A4S3	>75% (High)	Present	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A4S3
TCGA-A2-A4S2	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Lobular Carcinoma	TCGA-A2-A4S2
TCGA-A2-A4S0	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	NA	6-10 per 10 HPF (Medium)	Other	TCGA-A2-A4S0
TCGA-A2-A4RY	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A4RY
TCGA-A2-A4RX	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-A2-A4RX
TCGA-A2-A4RW	25-75% (Moderate) 	Absent	Present	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A4RW
TCGA-A2-A3Y0	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A3Y0
TCGA-A2-A3XZ	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A3XZ
TCGA-A2-A3XY	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A3XY
TCGA-A2-A3XX	>75% (High)	NA	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A3XX
TCGA-A2-A3XW	>75% (High)	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A3XW
TCGA-A2-A3XV	>75% (High)	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A3XV
TCGA-A2-A3XU	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A3XU
TCGA-A2-A3XT	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	NA	Invasive Ductal Carcinoma	TCGA-A2-A3XT
TCGA-A2-A3XS	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	NA	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-A2-A3XS
TCGA-A2-A3KD	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A2-A3KD
TCGA-A2-A3KC	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A3KC
TCGA-A2-A25F	25-75% (Moderate) 	Present	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Mixed	TCGA-A2-A25F
TCGA-A2-A25E	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Mixed	TCGA-A2-A25E
TCGA-A2-A25D	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A25D
TCGA-A2-A25C	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A25C
TCGA-A2-A25B	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A25B
TCGA-A2-A25A	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A25A
TCGA-A2-A259	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A259
TCGA-A2-A1G6	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	>75% (Well Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A1G6
TCGA-A2-A1G4	25-75% (Moderate) 	Absent	Absent	1-5% (Minimum)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A1G4
TCGA-A2-A1G1	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A1G1
TCGA-A2-A1G0	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A1G0
TCGA-A2-A1FZ	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A1FZ
TCGA-A2-A1FX	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-A2-A1FX
TCGA-A2-A1FW	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-A2-A1FW
TCGA-A2-A1FV	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A1FV
TCGA-A2-A0YT	<25% (Low)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0YT
TCGA-A2-A0YM	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0YM
TCGA-A2-A0YL	NA	Absent	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	NA	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0YL
TCGA-A2-A0YK	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0YK
TCGA-A2-A0YJ	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0YJ
TCGA-A2-A0YI	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A2-A0YI
TCGA-A2-A0YH	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0YH
TCGA-A2-A0YG	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0YG
TCGA-A2-A0YF	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0YF
TCGA-A2-A0YE	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0YE
TCGA-A2-A0YD	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0YD
TCGA-A2-A0YC	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0YC
TCGA-A2-A0T7	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0T7
TCGA-A2-A0T6	25-75% (Moderate) 	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0T6
TCGA-A2-A0T5	25-75% (Moderate) 	Absent	Absent	Absent	Present	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0T5
TCGA-A2-A0T4	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0T4
TCGA-A2-A0T3	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A2-A0T3
TCGA-A2-A0T2	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0T2
TCGA-A2-A0T1	NA	Present	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0T1
TCGA-A2-A0T0	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0T0
TCGA-A2-A0SY	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0SY
TCGA-A2-A0SX	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0SX
TCGA-A2-A0SW	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0SW
TCGA-A2-A0SV	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0SV
TCGA-A2-A0SU	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0SU
TCGA-A2-A0ST	25-75% (Moderate) 	Present	Absent	6-50% (Moderate)	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0ST
TCGA-A2-A0EY	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0EY
TCGA-A2-A0EX	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0EX
TCGA-A2-A0EW	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	NA	Other	TCGA-A2-A0EW
TCGA-A2-A0EV	25-75% (Moderate) 	Present	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0EV
TCGA-A2-A0EU	25-75% (Moderate) 	Present	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0EU
TCGA-A2-A0ET	>75% (High)	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0ET
TCGA-A2-A0ES	<25% (Low)	Present	Absent	Absent	Present	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A2-A0ES
TCGA-A2-A0ER	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	10-75% (Moderately Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A2-A0ER
TCGA-A2-A0EQ	<25% (Low)	Present	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0EQ
TCGA-A2-A0EP	<25% (Low)	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0EP
TCGA-A2-A0EO	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0EO
TCGA-A2-A0EN	<25% (Low)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0EN
TCGA-A2-A0EM	25-75% (Moderate) 	Absent	Absent	6-50% (Moderate)	Present	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A2-A0EM
TCGA-A2-A0D4	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0D4
TCGA-A2-A0D3	<25% (Low)	Absent	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0D3
TCGA-A2-A0D2	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	NA	Invasive Ductal Carcinoma	TCGA-A2-A0D2
TCGA-A2-A0D0	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0D0
TCGA-A2-A0CZ	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0CZ
TCGA-A2-A0CY	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0CY
TCGA-A2-A0CX	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0CX
TCGA-A2-A0CW	>75% (High)	Present	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0CW
TCGA-A2-A0CV	>75% (High)	Absent	Absent	Absent	Present	>75% (Well Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0CV
TCGA-A2-A0CU	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Present	Present	Moderate Increase in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A2-A0CU
TCGA-A2-A0CT	>75% (High)	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Mixed	TCGA-A2-A0CT
TCGA-A2-A0CS	25-75% (Moderate) 	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Present	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0CS
TCGA-A2-A0CR	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0CR
TCGA-A2-A0CQ	>75% (High)	Absent	Absent	>50% (Marked)	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0CQ
TCGA-A2-A0CP	<25% (Low)	Present	Absent	Absent	Present	>75% (Well Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0CP
TCGA-A2-A0CO	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0CO
TCGA-A2-A0CM	25-75% (Moderate) 	Present	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A0CM
TCGA-A2-A0CL	25-75% (Moderate) 	Present	Absent	1-5% (Minimum)	Absent	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A0CL
TCGA-A2-A0CK	25-75% (Moderate) 	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Small Regular Nuclei	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A2-A0CK
TCGA-A2-A04Y	>75% (High)	Absent	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-A2-A04Y
TCGA-A2-A04X	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A04X
TCGA-A2-A04W	25-75% (Moderate) 	Absent	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A2-A04W
TCGA-A2-A04V	25-75% (Moderate) 	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A2-A04V
TCGA-A2-A04U	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A04U
TCGA-A2-A04T	25-75% (Moderate) 	Present	Absent	Absent	Absent	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A04T
TCGA-A2-A04R	>75% (High)	Absent	Absent	Absent	Present	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A04R
TCGA-A2-A04Q	<25% (Low)	Present	Present	Absent	Present	<10% (poorly Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A04Q
TCGA-A2-A04P	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Present	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A2-A04P
TCGA-A2-A04N	>75% (High)	Absent	Absent	Absent	Absent	>75% (Well Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Other	TCGA-A2-A04N
TCGA-A1-A0SQ	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	0-5 per 10 high powered fields, HPF (Low)	Invasive Ductal Carcinoma	TCGA-A1-A0SQ
TCGA-A1-A0SP	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A1-A0SP
TCGA-A1-A0SN	NA	Absent	Absent	6-50% (Moderate)	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A1-A0SN
TCGA-A1-A0SM	25-75% (Moderate) 	Present	Absent	>50% (Marked)	Absent	10-75% (Moderately Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A1-A0SM
TCGA-A1-A0SK	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Present	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Other	TCGA-A1-A0SK
TCGA-A1-A0SJ	>75% (High)	Present	Absent	Absent	Present	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A1-A0SJ
TCGA-A1-A0SI	>75% (High)	Present	Present	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	>10 per 10 HPF (High)	Invasive Ductal Carcinoma	TCGA-A1-A0SI
TCGA-A1-A0SH	25-75% (Moderate) 	Present	Absent	Absent	Present	<10% (poorly Differentiated	Absent	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Mixed	TCGA-A1-A0SH
TCGA-A1-A0SF	25-75% (Moderate) 	Present	Absent	1-5% (Minimum)	Present	>75% (Well Differentiated	Present	Absent	Moderate to Marked Variation in Size	Absent	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A1-A0SF
TCGA-A1-A0SE	25-75% (Moderate) 	Absent	Present	Absent	Absent	<10% (poorly Differentiated	Present	Absent	Moderate Increase in Size	Multiple Fibrotic Foci	0-5 per 10 high powered fields, HPF (Low)	Invasive Lobular Carcinoma	TCGA-A1-A0SE
TCGA-A1-A0SD	25-75% (Moderate) 	Absent	Absent	>50% (Marked)	Present	10-75% (Moderately Differentiated	Absent	Present	Moderate to Marked Variation in Size	Multiple Fibrotic Foci	6-10 per 10 HPF (Medium)	Invasive Ductal Carcinoma	TCGA-A1-A0SD
TCGA-A1-A0SB	>75% (High)	Absent	Absent	Absent	Absent	<10% (poorly Differentiated	Absent	Absent	Moderate Increase in Size	Absent	6-10 per 10 HPF (Medium)	Other	TCGA-A1-A0SB
